Pharmaceutical Composition Comprising Lipoic Acid and Taurine as Osmoprotective Agent
Summary
The EPO granted Patent EP3297733A1 to Dulcis Health Science for a pharmaceutical composition combining lipoic acid and taurine as an osmoprotective agent. The patent, published April 8, 2026, lists inventors Claret, Martine, Claret, Claude, and Chatard-Baptist, Caroline, with designations covering all 31 European Patent Convention member states.
What changed
The EPO granted EP3297733A1, a patent for pharmaceutical compositions comprising lipoic acid and taurine as osmoprotective agents. The patent covers various formulations including topical, oral, and injectable preparations, classified under A61K and A23L categories.
For pharmaceutical companies and researchers developing osmoprotective formulations, this patent establishes proprietary rights in the European market. Competitors may need to pursue licensing negotiations or develop non-infringing alternatives to commercialize similar products in EPC-designated states.
What to do next
- Monitor for potential infringement if developing competing osmoprotective formulations
- Review patent claims to assess freedom to operate
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF LIPOIC ACID AND TAURINE AS OSMOPROTECTIVE AGENT
Publication EP3297733A1 Kind: A1 Apr 08, 2026
Applicants
DULCIS HEALTH SCIENCE
Inventors
CLARET, Martine, CLARET, Claude, CHATARD-BAPTISTE, Caroline
IPC Classifications
A61K 31/185 20060101AFI20260127BHEP A61K 31/385 20060101ALI20260127BHEP A61K 8/46 20060101ALI20260127BHEP A23L 33/10 20160101ALI20260127BHEP A23L 33/12 20160101ALI20260127BHEP A23L 33/175 20160101ALI20260127BHEP A61K 8/49 20060101ALI20260127BHEP A61K 9/00 20060101ALI20260127BHEP A61K 9/06 20060101ALI20260127BHEP A61K 9/14 20060101ALI20260127BHEP A61P 17/00 20060101ALI20260127BHEP A61P 27/00 20060101ALI20260127BHEP A61Q 19/00 20060101ALI20260127BHEP A61P 27/02 20060101ALI20260127BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Dulcis Health.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.